Expert neuroscientists who study age-related memory loss at all four McKnight Brain Institutes in the U.S. came together in Gainesville for 11th annual meeting.
Three renowned neuroscientists from top U.S. research institutions — Drs. Malú G. Tansey, Ph.D., Matthew LaVoie, Ph.D., and Stefan Prokop, M.D. — will join the newly established Norman Fixel Institute for Neurological Diseases at UF Health.
NIAA Director Dr. George Koob discussed the state of alcohol use disorders in the U.S. and the pursuit of new treatment targets during the seventh annual Luttge Lectureship in Neuroscience.
A team led by Cara Croft, Ph.D., has demonstrated a novel method to model Alzheimer’s disease and Parkinson’s disease pathologies and seek potential therapeutic targets. Learn more:
A team of UF researchers were featured on the cover of the Journal of Biological Chemistry’s year in review edition, highlighting 2018’s most exciting and significant research.
See media highlights stemming from Jan. 18’s Norman Fixel Institute for Neurological Diseases at UF Health gift announcement.
Funds will help launch institute at UF Health for Parkinson’s and other neurodegenerative diseases.
In the journal Science, MBI leaders Drs. Steven DeKosky and Todd Golde discuss the challenges of developing effective Alzheimer’s therapies and the road ahead.
MBI and 1Florida ADRC Director Todd Golde, M.D., Ph.D., shines light on UF’s role in a nationwide initiative to combat the disease and his hopes for the future
MBI director Dr. Todd Golde facilitated a Research!America Town Hall panel including Mary Woolley, retired U.S. Rep. John Edward Porter, Dr. Stephen Sugrue and Dr. David Norton.